RhumbLine Advisers’s Quest Diagnostics DGX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $56.7M | Buy |
267,727
+4,380
| +2% | +$860K | 0.04% | 348 |
|
|
2026
Q1 | $51.6M | Sell |
263,347
-13,116
| -5% | -$2.55M | 0.04% | 342 |
|
|
2025
Q4 | $48M | Buy |
276,463
+2,017
| +0.7% | +$367K | 0.04% | 361 |
|
|
2025
Q3 | $52.3M | Sell |
274,446
-5,282
| -2% | -$937K | 0.04% | 349 |
|
|
2025
Q2 | $50.2M | Sell |
279,728
-7,490
| -3% | -$1.3M | 0.04% | 356 |
|
|
2025
Q1 | $48.6M | Buy |
287,218
+7,578
| +3% | +$1.24M | 0.05% | 345 |
|
|
2024
Q4 | $42.2M | Sell |
279,640
-8,647
| -3% | -$1.34M | 0.04% | 393 |
|
|
2024
Q3 | $44.8M | Sell |
288,287
-4,903
| -2% | -$732K | 0.04% | 373 |
|
|
2024
Q2 | $40.1M | Buy |
293,190
+177
| +0.1% | +$24.2K | 0.04% | 383 |
|
|
2024
Q1 | $39M | Buy |
293,013
+9,968
| +4% | +$1.29M | 0.04% | 399 |
|
|
2023
Q4 | $39M | Sell |
283,045
-6,764
| -2% | -$889K | 0.04% | 378 |
|
|
2023
Q3 | $35.3M | Sell |
289,809
-3,426
| -1% | -$456K | 0.04% | 383 |
|
|
2023
Q2 | $41.2M | Sell |
293,235
-339
| -0.1% | -$46.7K | 0.05% | 348 |
|
|
2023
Q1 | $41.5M | Sell |
293,574
-12,443
| -4% | -$1.78M | 0.05% | 327 |
|
|
2022
Q4 | $47.9M | Buy |
306,017
+1,999
| +0.7% | +$287K | 0.06% | 281 |
|
|
2022
Q3 | $37.3M | Buy |
304,018
+2,757
| +0.9% | +$363K | 0.06% | 314 |
|
|
2022
Q2 | $40.1M | Buy |
301,261
+20,987
| +7% | +$2.86M | 0.06% | 287 |
|
|
2022
Q1 | $38.4M | Buy |
280,274
+2,732
| +1% | +$381K | 0.05% | 329 |
|
|
2021
Q4 | $48M | Buy |
277,542
+1,926
| +0.7% | +$293K | 0.06% | 287 |
|
|
2021
Q3 | $40M | Sell |
275,616
-14,819
| -5% | -$2.17M | 0.05% | 307 |
|
|
2021
Q2 | $38.3M | Buy |
290,435
+168
| +0.1% | +$22K | 0.05% | 329 |
|
|
2021
Q1 | $37.3M | Buy |
290,267
+2,010
| +0.7% | +$248K | 0.05% | 328 |
|
|
2020
Q4 | $34.4M | Sell |
288,257
-21,407
| -7% | -$2.61M | 0.05% | 350 |
|
|
2020
Q3 | $35.5M | Sell |
309,664
-35,234
| -10% | -$4.16M | 0.06% | 298 |
|
|
2020
Q2 | $39.3M | Sell |
344,898
-63,618
| -16% | -$6.75M | 0.07% | 262 |
|
|
2020
Q1 | $32.8M | Buy |
408,516
+40,695
| +11% | +$4.21M | 0.07% | 258 |
|
|
2019
Q4 | $39.3M | Buy |
367,821
+13,437
| +4% | +$1.4M | 0.07% | 277 |
|
|
2019
Q3 | $37.9M | Buy |
354,384
+9,114
| +3% | +$936K | 0.07% | 259 |
|
|
2019
Q2 | $35.2M | Buy |
345,270
+44,024
| +15% | +$4.23M | 0.07% | 278 |
|
|
2019
Q1 | $27.1M | Sell |
301,246
-17,160
| -5% | -$1.49M | 0.05% | 328 |
|
|
2018
Q4 | $26.5M | Sell |
318,406
-4,082
| -1% | -$383K | 0.06% | 305 |
|
|
2018
Q3 | $34.8M | Buy |
322,488
+11,639
| +4% | +$1.28M | 0.07% | 285 |
|
|
2018
Q2 | $34.2M | Sell |
310,849
-3,251
| -1% | -$339K | 0.07% | 284 |
|
|
2018
Q1 | $31.5M | Sell |
314,100
-5,728
| -2% | -$587K | 0.07% | 298 |
|
|
2017
Q4 | $31.5M | Sell |
319,828
-1,175
| -0.4% | -$111K | 0.06% | 300 |
|
|
2017
Q3 | $30.1M | Buy |
321,003
+13,503
| +4% | +$1.43M | 0.07% | 294 |
|
|
2017
Q2 | $34.2M | Sell |
307,500
-20,049
| -6% | -$2.12M | 0.08% | 266 |
|
|
2017
Q1 | $32.2M | Sell |
327,549
-8,116
| -2% | -$774K | 0.08% | 278 |
|
|
2016
Q4 | $30.8M | Buy |
335,665
+57,769
| +21% | +$4.98M | 0.08% | 266 |
|
|
2016
Q3 | $23.5M | Buy |
277,896
+11,040
| +4% | +$927K | 0.06% | 298 |
|
|
2016
Q2 | $21.7M | Buy |
266,856
+19,921
| +8% | +$1.52M | 0.06% | 301 |
|
|
2016
Q1 | $17.6M | Buy |
246,935
+44,727
| +22% | +$3M | 0.05% | 337 |
|
|
2015
Q4 | $14.4M | Sell |
202,208
-889
| -0.4% | -$59.8K | 0.05% | 392 |
|
|
2015
Q3 | $12.5M | Buy |
203,097
+2,303
| +1% | +$161K | 0.04% | 427 |
|
|
2015
Q2 | $14.6M | Buy |
200,794
+9,839
| +5% | +$726K | 0.05% | 393 |
|
|
2015
Q1 | $14.7M | Sell |
190,955
-840
| -0.4% | -$60.2K | 0.04% | 382 |
|
|
2014
Q4 | $12.9M | Sell |
191,795
-1,582
| -0.8% | -$99.8K | 0.04% | 418 |
|
|
2014
Q3 | $11.7M | Sell |
193,377
-5,504
| -3% | -$339K | 0.04% | 432 |
|
|
2014
Q2 | $11.7M | Sell |
198,881
-13,208
| -6% | -$773K | 0.03% | 441 |
|
|
2014
Q1 | $12.3M | Sell |
212,089
-7,613
| -3% | -$408K | 0.04% | 427 |
|
|
2013
Q4 | $11.8M | Sell |
219,702
-24,788
| -10% | -$1.47M | 0.03% | 436 |
|
|
2013
Q3 | $15.1M | Buy |
244,490
+1,715
| +0.7% | +$103K | 0.05% | 373 |
|
|
2013
Q2 | $14.7M | Buy |
+242,775
| New | +$14.5M | 0.05% | 356 |
|
Other funds holding DGX
EIG
RhumbLine Advisers's DGX Position: Q2 2026 in Review
RhumbLine Advisers increased its Quest Diagnostics (DGX) stake by 1.7% in Q2 2026, buying an estimated $860K and bringing the position to 267,727 shares worth $56.7M. The position accounts for 0.04% of the portfolio, ranked #348.
RhumbLine Advisers first reported a position in DGX in Q2 2013 and has held it in 53 quarters since. 1,099 funds tracked by Wall St. Rank hold DGX as of Q2 2026.
- RhumbLine Advisers held 267,727 shares of Quest Diagnostics worth $56.7M as of Q2 2026.
- RhumbLine Advisers bought 4,380 Quest Diagnostics shares in Q2 2026, an estimated $860K.
- Quest Diagnostics made up 0.04% of RhumbLine Advisers's portfolio in Q2 2026, its #348 holding.
- RhumbLine Advisers first reported a position in Quest Diagnostics in Q2 2013 and has held it in 53 quarters since.
- 1,099 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2026.
Based on RhumbLine Advisers's 13F filing for Q2 2026, filed 12 Aug 2026.